GoodRx (GDRX) Competitors $3.79 -0.18 (-4.53%) Closing price 04:00 PM EasternExtended Trading$3.81 +0.02 (+0.53%) As of 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GDRX vs. QXO, GLOB, MARA, WSC, AMTM, RELY, ETSY, TNET, FTDR, and STNEShould you be buying GoodRx stock or one of its competitors? The main competitors of GoodRx include QXO (QXO), Globant (GLOB), MARA (MARA), WillScot Mobile Mini (WSC), Amentum (AMTM), Remitly Global (RELY), Etsy (ETSY), TriNet Group (TNET), Frontdoor (FTDR), and StoneCo (STNE). These companies are all part of the "business services" industry. GoodRx vs. QXO Globant MARA WillScot Mobile Mini Amentum Remitly Global Etsy TriNet Group Frontdoor StoneCo GoodRx (NASDAQ:GDRX) and QXO (NASDAQ:QXO) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, community ranking, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends. Does the media favor GDRX or QXO? In the previous week, QXO had 2 more articles in the media than GoodRx. MarketBeat recorded 11 mentions for QXO and 9 mentions for GoodRx. QXO's average media sentiment score of 1.23 beat GoodRx's score of 0.94 indicating that QXO is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GoodRx 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive QXO 7 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of GDRX or QXO? 63.8% of GoodRx shares are owned by institutional investors. Comparatively, 58.7% of QXO shares are owned by institutional investors. 4.5% of GoodRx shares are owned by company insiders. Comparatively, 51.3% of QXO shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is GDRX or QXO more profitable? QXO has a net margin of 30.08% compared to GoodRx's net margin of -2.05%. GoodRx's return on equity of 5.35% beat QXO's return on equity.Company Net Margins Return on Equity Return on Assets GoodRx-2.05% 5.35% 2.51% QXO 30.08%1.58%1.30% Does the MarketBeat Community prefer GDRX or QXO? GoodRx received 74 more outperform votes than QXO when rated by MarketBeat users. CompanyUnderperformOutperformGoodRxOutperform Votes7439.57% Underperform Votes11360.43% QXON/AN/A Which has preferable valuation & earnings, GDRX or QXO? QXO has lower revenue, but higher earnings than GoodRx. QXO is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGoodRx$797.41M1.74-$8.87M$0.0848.69QXO$55.95M129.78-$1.07M-$10.05-1.62 Do analysts recommend GDRX or QXO? GoodRx currently has a consensus target price of $6.55, suggesting a potential upside of 68.05%. Given GoodRx's stronger consensus rating and higher probable upside, research analysts clearly believe GoodRx is more favorable than QXO.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GoodRx 0 Sell rating(s) 5 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.64QXO 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk and volatility, GDRX or QXO? GoodRx has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500. Comparatively, QXO has a beta of 2.27, indicating that its stock price is 127% more volatile than the S&P 500. SummaryGoodRx beats QXO on 10 of the 18 factors compared between the two stocks. Get GoodRx News Delivered to You Automatically Sign up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GDRX vs. The Competition Export to ExcelMetricGoodRxData processing & preparation IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.39B$4.28B$5.40B$8.53BDividend YieldN/A3.85%5.22%4.11%P/E Ratio-130.1785.6626.7419.97Price / Sales1.741,487.27394.93122.22Price / Cash11.7733.7438.2534.62Price / Book2.026.436.874.59Net Income-$8.87M$44.05M$3.23B$248.18M7 Day Performance-8.78%-0.95%5.01%2.15%1 Month Performance-10.87%28.52%12.82%16.14%1 Year Performance-45.60%19.61%17.63%8.06% GoodRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GDRXGoodRx3.8363 of 5 stars$3.79-4.5%$6.55+72.7%-44.3%$1.35B$797.41M-126.33950Gap UpQXOQXO1.0955 of 5 stars$14.43+4.1%N/AN/A$6.45B$56.87M-1.58195News CoveragePositive NewsGap DownGLOBGlobant4.6412 of 5 stars$138.73+7.7%$204.00+47.1%-38.0%$6.11B$2.42B37.2927,100Earnings ReportAnalyst UpgradeHigh Trading VolumeMARAMARA3.7858 of 5 stars$15.95+1.2%$20.50+28.5%-27.5%$5.61B$705.06M20.199Trending NewsInsider TradeWSCWillScot Mobile Mini4.1655 of 5 stars$29.65+10.1%$40.63+37.0%-30.8%$5.44B$2.37B197.684,500Positive NewsGap UpAMTMAmentum2.1715 of 5 stars$21.34+0.6%$25.38+18.9%N/A$5.19B$12.51B0.0053,000Positive NewsAnalyst ForecastGap UpRELYRemitly Global3.6776 of 5 stars$24.49+2.7%$29.13+18.9%+58.1%$4.99B$1.36B-128.892,700Insider TradeHigh Trading VolumeETSYEtsy3.7137 of 5 stars$47.59+1.4%$50.14+5.4%-26.5%$4.96B$2.81B20.082,790TNETTriNet Group3.9891 of 5 stars$84.54+3.2%$96.67+14.3%-17.0%$4.09B$5.06B24.723,600Positive NewsFTDRFrontdoor3.052 of 5 stars$54.74+3.0%$49.00-10.5%+53.1%$4.03B$1.89B18.132,080Positive NewsSTNEStoneCo4.3546 of 5 stars$13.42-1.7%$15.38+14.6%-10.0%$3.84B$12.74B10.4815,500Positive News Related Companies and Tools Related Companies QXO Competitors Globant Competitors MARA Competitors WillScot Mobile Mini Competitors Amentum Competitors Remitly Global Competitors Etsy Competitors TriNet Group Competitors Frontdoor Competitors StoneCo Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GDRX) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GoodRx Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GoodRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GDRX Stock Free GDRX Stock Alerts